{"id":"W2624322160","doi":"10.1111/bjd.15723","title":"Infections from seven clinical trials of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriasis","year":2017,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":51,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Psoriasis; Medicine; Interleukin 17; Monoclonal antibody; Immunology; Clinical trial; Dermatology; Monoclonal; Interleukin; Plaque psoriasis; Antibody; Internal medicine; Cytokine; Secukinumab; Psoriatic arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00900782,0.0007310117,0.00361612,0.00131066,0.0003715094,0.001591298,0.0007465737,0.000811022,0.001961444],"category_scores_gemma":[0.01014166,0.000535214,0.004212887,0.002469258,0.0004568184,0.0005915375,0.0007951735,0.001117481,0.0001752486],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008200727,"about_ca_system_score_gemma":0.001760911,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006233628,"about_ca_topic_score_gemma":0.002315783,"domain_scores_codex":[0.9906068,0.004316225,0.002590835,0.0007889535,0.001385566,0.0003115514],"domain_scores_gemma":[0.9882987,0.00650814,0.003695351,0.0005020755,0.0006273814,0.00036842],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"systematic_review","study_design_scores_codex":[0.3865351,0.002986762,0.0970273,0.08685832,0.1168264,0.0006341889,0.0006419871,0.002751725,0.01202486,0.0005585937,0.006956609,0.2861981],"study_design_scores_gemma":[0.3932773,0.1230423,0.2702949,0.01339758,0.1574615,0.002816617,0.000545327,0.0009534841,0.005871661,0.0009157752,0.03119745,0.0002261801],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.6637675,0.3184563,0.001208712,0.0005436008,0.0001223386,0.004123497,0.007807822,0.00008030736,0.003889926],"genre_scores_gemma":[0.8933497,0.09038889,0.002231488,0.0009838009,0.0002340351,0.003012517,0.009199252,0.00002825073,0.0005720914],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.00900782,"threshold_uncertainty_score":0.04763854,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09830212884903328,"score_gpt":0.3960104618528332,"score_spread":0.2977083330038,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}